03794
Strontium atomic spectroscopy standard concentrate 1.00 g Sr
1.00 g/L, for 1L standard solution, analytical standard
Synonym(s):
Strontium chloride solution
grade
analytical standard
shelf life
limited shelf life, expiry date on the label
packaging
ampule of
solubility
H2O: soluble
SMILES string
[Sr]
InChI
1S/Sr
InChI key
CIOAGBVUUVVLOB-UHFFFAOYSA-N
Preparation Note
prepared with SrCl2 and H2O
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1
Storage Class
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J K Badawi
Deutsche medizinische Wochenschrift (1946), 137(33), 1645-1649 (2012-08-10)
Many patients suffering from urological or non-urological malignancies develop bone metastases. One symptom often found is severe skeletal pain which siginificantly lowers the quality of life. Further symptoms are pathological fractures, spinal cord compression and hypercalcemia. The systemic radiopharmaceutical therapy
Hiroshi Ikeda et al.
Gan to kagaku ryoho. Cancer & chemotherapy, 39(1), 63-68 (2012-01-14)
Strontium-89 chloride has been available at our hospital for painful osseous metastases since October 2008. Of the 17 patients(22 treatments)seen until September 2010, response to initial treatment of 13 patients was analyzed. These included cancers of the lung(5 patients, 6
D K Fomin et al.
Vestnik rentgenologii i radiologii, (2)(2), 29-31 (2012-06-27)
To study the efficiency of treatment via single administration of high-purity 89Sr chloride in the standard activity of 150 MBq for pain syndrome in patients with multiple bone metastases. The authors carried out clinical trials of high-purity 89Sr chloride used
Bernhard Pemmer et al.
Journal of synchrotron radiation, 18(Pt 6), 835-841 (2011-10-15)
Based on clinical trials showing the efficacy to reduce vertebral and non-vertebral fractures, strontium ranelate (SrR) has been approved in several countries for the treatment of postmenopausal osteoporosis. Hence, it is of special clinical interest to elucidate how the Sr
Salil Vengalil et al.
Current opinion in supportive and palliative care, 6(3), 310-315 (2012-06-20)
Bone metastases in prostate cancer are often the cause of significant morbidity in patients with castrate-resistant disease, and several studies have shown significant pain palliation with systemic radionuclide treatment. The purpose of this review is to discuss the place of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service